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KYRTl, A DISARMED VERSION OF A

for transferring agronomically useful genes to plants.
Recently it has been demonstrated that foreign DNA,

HIGHLY TUMORIGENIC AGROBA C TERI UM
TUMEFACIENS STRAIN IDENTIFIED AS
CHRY5

?anked by T-DNA border sequences, can be transferred into

plant cells using A. tumefaciens as the vector (Hernalsteens
et al., Nature 287:654—65 6, 1980). Furthermore, inactivation
or removal of the native T-DNA genes involved in hormone

TECHNICAL FIELD

The invention relates to novel disarmed Agrobacterium
tumefaciens vectors useful for the transformation of plants.
More particularly, the invention relates to disarmed A.
tumefaciens vectors, methods of their use and transgenic

synthesis Would render the A. tumefaciens incapable of
producing the croWn gall disease symptoms. This process of
inactivating or removing genes responsible for disease
10

plants, particularly dicotyledonous transgenic plants, created

the simultaneous disarming and introduction of the desired
gene, since the introduced gene directly replaced the genes
in the T-DNA. By a method termed “homogenotiZation”

thereby. Yet more particularly, the invention relates to dis

armed A. tumefaciens strain designated KYRT1 and meth
ods of its use and transgenic soybean plants made thereby.
15

desired gene for transformation. Homologous recombina
tion occurred betWeen the T-DNA of the Ti plasmid and an

Soybean is an agronomically important crop. Despite this
importance, hoWever, there is only limited breeding poten

intermediate construct in a broad host range plasmid, con
20

oping techniques to modify soybean characteristics through

broad host range plasmid incompatible to the intermediate

possibility of developing plant lines that have speci?c,
drought resistance, heat resistance, disease resistance, seed
quality improvement, and the like, in Ways not possible
using traditional breeding techniques. Due to the successes
of Agrobacterium tumefaciens-mediated gene transfer in
other plant species, much effort has been placed on devel
oping such a system for the genetic modi?cation of soybean.
To date, hoWever, these efforts have met With only limited

construct, and selecting for drug-resistance encoded by the
25

selectable marker gene of the introduced T-DNA in the
desired construct, and the drug-resistance gene on the

incompatible plasmid.
Another strategy developed for engineering A. tumefa
30

success, With generally loW transformation ef?ciencies on

most soybean cultivars.
Agrobacterium tumefaciens is a gram-negative soil bac
teria that causes the croWn gall disease in plants by infecting

taining the desired gene and a selectable marker (e.g., drug
resistance) ?anked by T-DNA sequences. The recombination
event Was forced by a subsequent introduction of a second

the use of genetic engineering. Such modi?cations offer the
tailor-made bene?cial traits, such as herbicide resistance,

(MatZke and Chilton, J. Mol. Appl. Genet. 1: 39—49, 1981),
the native T-DNA of the Ti plasmid Was replaced With a

BACKGROUND ART

tial in the United States due to a small germplasm base. As
a result, tremendous efforts have been expended in devel

symptoms is termed “disarming.”
The ?rst methods of A. tumefaciens engineering involved

ciens involved cloning the desired gene into a cointegrative
intermediate vector, Which contained a single region of
T-DNA homology and a single border sequence. In this
system, the sequences are recombined by a single-crossover

event (Horsch et al., Science 227: 1229—1231, 1985), Which
results in the entire vector, including the gene of interest,
35

being integrated. Cointegrative systems pair in regions of
homology betWeen the T-DNA region of the Ti plasmid and

cells through Wound sites. A. tumefaciens infects by inject

the DNA sequence on the introduced integrative vector.

ing into the cell a strand of DNA (termed T-DNA) derived

One example of a useful cointegrative plasmid is
pGV3850, a Ti plasmid from a nopaline strain (C58), from

from the large tumor-inducing (Ti) plasmid (van Larebeke et
al., Nature 255: 742—743, 1975). The T-DNA then integrates

40

into a chromosomal location in the plant and produces

Which the entire T-DNA region betWeen the borders Was

enZymes that synthesiZe hormones Which cause the croWn

replaced With pBR322, thus offering a recombination site for
any gene construct containing pBR322 homology

gall symptoms (Chilton et al., Cell 11: 263—271, 1977). The
genes encoding these enZymes, and the eukaryotic regula

(Zambryski et al., EMBO J. 2(12): 2143—2150, 1983).

the T-DNA. In addition, the integrated T-DNA also encodes
products that direct the synthesis of compounds knoWn as
opines, Which are amino acid and sugar derivatives, Which
varies depending upon the A. tumefaciens strain.
Mobilization of the T-DNA requires that the products of

Technol. 1: 262—269, 1983; Hoekema et al., Nature 303:

Upon the discovery that T-DNA does not have to be on the
tory control elements associated thereWith, are located on 45 same plasmid as the vir genes (de Framond et al., Bi0/

179—180, 1983), the binary vector Was developed. A binary
vector is maintained in the A. tumefaciens separate from the
Ti plasmid, and contains the gene of interest and a selectable
marker gene betWeen T-DNA border sequences. These vec

genes located elseWhere on the Ti plasmid, called collec
tively the vir genes, Which are activated by certain elicitors
from the Wounded plant cells in trans to synthesiZe and

transfer a single-stranded copy of the T-DNA (the T-strand)
to the plant cell (Zambryski,Ann. Rev. Plant. Physiol. Plant
Mol. Biol. 43: 465—490, 1992; Zupan and Zambryski, Plant
Physiol. 107: 1041—1047, 1995). The T-DNA sequence on
the Ti plasmid is ?anked by short 24-bp direct repeats
(Yadav et al., Proc. Natl. Acad. Sci. (USA), 1982), Which are
required for the recognition of the T-DNA (Wang et al., Cell

tors offer a great degree of ?exibility, since they do not
require a speci?cally engineered Ti plasmid With a homolo
gous recombination site. For that reason, any disarmed A.
tumefaciens strain can be used to transfer genes for any
55

currently the preferred intermediate vectors for cloning
genes destined for A. tumefaciens-mediated transfer into
plants. HoWever, any A. tumefaciens strain to be used With
binary vectors must have its oWn Ti plasmid disarmed,
60

38: 455—462, 1984). Sequences immediately surrounding

especially if the target plant species is inef?ciently trans
formed viaA. tumefaciens. OtherWise, the desired gene from
the binary vector Will be co-transformed With the oncogenic
phytohormone genes from the native T-DNA of the bacteria,

these borders appear to be involved in the polarity of

T-strand synthesis, Which initiates at the right border (Wang
et al., Mol. Gen. Genet. 210: 338—346, 1987).
The discovery of the mechanism by Which A. tumefaciens
infects plant cells, i.e. by DNA transfer, led to the realiZation
that this microorganism might be useful, via its Ti plasmid,

binary vector. OWing to their versatility, binary vectors are

65

thereby reducing transformation ef?ciency of the desired
gene and also producing the tumorigenic disease symptoms
in many of the target cells and thereby preventing the
differentiation of these cells into normal plants.

5,929,306
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supervirulent, broad host-range, L,L-succinamopine-type A.

Disarming Wild-type A. tumefaciens strains for general
use With binary vectors has involved, in some cases, a form

tumefaciens strain that shoWs high virulence on soybean.

of homogenotiZation. An intermediate construct containing

Strain A281 has a nopaline-type C58 chromosomal

a marker gene ?anked by Ti plasmid sequences that are

background, containing the L,L-succinamopine-type Ti
plasmid, pTiBo542, and out-performs its chromosomal and
Ti plasmid progenitors on soybean (Hood et al., Plant
Physiol. 83: 529—534, 1987). Disarming this strain has

homologous to regions that lie outside the T-DNA, is intro

duced into the Wild-type A. tumefaciens by bacterial conju
gation (Hood et al., J. Bacteriol. 168(3): 1291—1301, 1986;
Hood et al., Transgenic Res. 2: 208—218, 1993). Whereas
disarmed A. tumefaciens strains typically have their entire
T-DNA sequences removed, it has also been demonstrated
that T-DNA mobiliZation can be inactivated by removal of

produced EHA101 and EHA105, strains noW Widely used in
10

Physiol. 83: 529—534, 1987).
Recently, Chry5, another L,L-succinamopine-type strain

the right border sequence: reports from Work With nopaline
type strains of A. tumefaciens shoW that the right border of
T-DNA is necessary for gene transfer, Whereas the left
border is not. (Joos et al., Cell 32: 1057—1067, 1983; Peralto
and Ream, Proc. Natl. Acad. Sci. (USA), 1985; ShaW et al.,
NucleicAcids Res., 12: 6031—6041, 1984; Wang et al., Mol.
Gen. Genet. 210: 338—346, 1984).

of A. tumefaciens recovered from chrysanthemum, has been
found to have a broad host range, and is also highly virulent
15

nopaline-type, and L,L-succinamopine-type, named after
type of opine synthesiZed in the plant cells they infect. These
strains have comparable, although not identical, host ranges
and disarmed versions of many types of A. tumefaciens have
been used successfully for gene transfer into a variety of

homology to pTiBo542 in supervirulent strain A281. The
Chry5 strain also possesses a cryptic plasmid, the purpose of
20

Which is unclear. Based on stem inoculation assays, Chry5

rivals A281 (Hood et al., Plant Physiol. 83: 529—534, 1987)
for tumorigenicity on soybean.
The sequences of pTiChry5 have been subcloned as
25

partial EcoRI fragments into a cosmid library in pLAFR1
(Friedman et al., Gene 18: 289—296, 1982), and mapped for
EcoRI and BamHI sites and for vir, inc, L,L-succinamopine
utiliZation, and the T-DNA regions, based on homology to

plant species. (van Wordragen et al., Plant Mol. Biol. Rep.
10: 12—36, 1992; Hood et al., Transgenic Res. 2: 208—218,
1993). Although its most sensitive hosts are members of the
dicot family Solanaceae, A. tumefaciens, as mentioned

on soybean (Bush and Pueppke, Appl. Environm. Microbiol.

57(9): 2468—2472, 1991). The Ti plasmid of this strain,
designated pTiChry5, is comparable in arrangement and

A. tumefaciens has a diverse dicot host range, and addi

tionally some monocot families (De Cleene and De Layk,
Bot. Rev. 42 (4): 389—466, 1976). There are several different
strains of A. tumefaciens, each classi?ed into octopine-type,

conjunction With soybean transformation (Hood et al., J.
Bacteriol. 168(3): 1283—1290, 1986; Hood et al., Plant

30

pTiBo542 of A281. Observations from complementation
analysis suggest key cis-acting elements in pTiChry5 near
the T-DNA right border as being involved With superviru

above, has also been demonstrated to infect some monocots

lence. HoWever, studies involving transferring pTiChry5

as Well (Smith and Hood, Crop Sci. 35(2): 301—309, 1995).

into other A. tumefaciens strains suggest that there may also
be chromosomal involvement in the hypervirulence of

HoWever, soybean (Glycine max L. Merr.) has proven to
be very di?icult to transform With A. tumefaciens, at least in

part because it is refractory to infection by Wild-type A.
tumefaciens. Comparative studies With a number of soybean
cultivars and A. tumefaciens strains suggest that soybean
susceptibility to A. tumefaciens is limited, and is both
cultivar- and bacterial strain dependent (Bush and Pueppke,

Chry5 observed With soybean (Kovacs and Pueppke, Mol.
35

Gen. Genet. 242: 327—336, 1994).
US. Pat. No. 5,416,011 discloses a method for the trans

40

Appl. Environ. Microbiol. 57(9): 2468—2472, 1991; Byrne et

formation of soybean, With a disarmed strain of A. tumefa
ciens designated A208. The [3-glucuronidase gene under the
control of the cauli?ower mosaic virus (CMV) 35S promoter
is disclosed as being useful for the determination of trans

al., Plant Cell Tiss. Org. Cult. 8: 3—15, 1987; Hood et al.,

formation e?iciency.

Plant Physiol. 83:529—534, 1987). The problems With soy

International Patent Application WO 94/02620 discloses
transformation of soybean using a disarmed A. tumefaciens
designated LBA 4404 and the induction of bacterial viru
lence by culture in media having a pH beloW 6.0.
Kovacs and Peuppke (Mol. Gen. Genet. 242: 327—336,

bean recalcitrance to A. tumefaciens are further complicated

by the difficulty of Working With soybean in tissue culture.
Progress in A. tumefaciens-mediated gene transfer in
soybean is limited by tWo major factors: (1) development of
a soybean tissue culture system that e?iciently regenerates
plants from a single-cell origin (Cheng et al., Plant Sci. Let.
19: 91—99, 1980; Wright et al., Plant Cell Rep. 5: 150—154,
1986), and (2) further understanding of the mechanism for
A. tumefaciens-mediated gene transfer, i.e., the fact that
certain chemical elicitors applied externally (e.g.,
acetosyringone) can stimulate vir gene activation and
T-DNA transfer into cells of non-host plants such as soybean

45

1994) discloses the genomic organiZation and restriction
endonuclease mapping of the Ti plasmid pTiChry5. That
publication further discloses that A. tumefaciens Chry5 is a
highly tumorigenic strain that has the ability to transform

soybean.
Kovacs et al. (Mol. Gen. Genet. 242: 327—336, 1993)
disclose that a cryptic plasmid and the bacterial chromosome
55

(OWens and Smigocki, Plant Physiol. 88: 570—573, 1988;

of strain Chry5 potentiate the tumorigenic ability of several
different Ti plasmids in comparison to their normal genetic

Stachel et al., Nature 318: 624—629, 1985).
One system for soybean A. tumefaciens-mediated gene

background.

transfer has noW been established, and is in Wide use

No. 678B, 1991) brie?y describes a plasmid-cured A. tame
faciens derivative of Chry5 into Which the Ti plasmid of

(ToWnsend, International Patent Application WO 94/02620,

Kovacs and Peuppke (Phytopathology, 81 (10): Abstract
60

strain T37 Was conjugated.

1994; Hinchee and Conner-Ward, US. Pat. No. 5,416,011,
1995). Despite these advances to date, hoWever, A.
tumefaciens-mediated gene transfer into soybean remains
ine?icient and labor-intensive, and methods for improving

that efficiency are continually being sought.
As mentioned earlier, some A. tumefaciens strains infect
soybean more readily than others. One strain, A281, is a

Bush and Pueppke (Appl. Environm. Micorbiol. 57(9):
2468—2472, 1991) discusses the characteriZation ofA. tame
65

faciens Chry5, isolated from naturally-occurring croWn galls
on Chrysanthemum morifolium. Strain Chry5 is thought to
be a biotype I strain that transforms at least 10 different plant

species.
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Hood et al. (Transgenic Res. 2:208—218, 1993) discloses
the disarming of three Ti plasmids: one each of the octopine,

24-kb cloned fragment of pTiChry5 in cosmid pLAF R1, and
replacing it With a gene conferring antibiotic (carbenicillin)

nopaline and L,L-succinamopine types. A. tumefaciens

resistance. The resulting construct is introduced into A.

strains A281 and EHA101 are disclosed as able to transform

tumefaciens Chry5 by bacterial conjugation and a homolo

soybean. The disarming derivative of plasmid pTiBo542

gous recombinant betWeen the construct and pTiChry5 is

from strain A281 is disclosed and designated pEHA105.
Hinchee et al. (Gene Manipulation in Plant Improvement
11, pp. 203—212, J P Gustafson, ed., Plenum Press, NeW

selected for by the subsequent conjugation of the incompat
ible group P plasmid pPH1JI. The resulting recombinantA.
tumefaciens strain Was named KYRT1. The transformation

ef?ciency of KYRT1 and comparative examples (including

York, 1990) discusses transformation of soybean by A.
tumefaciens, Wherein out of 100 cultivars of soybean tested
for transformation, only three Were found susceptible in
repeated tests. Also reported is a [3-glucuronidase gene
marker system.

Kudirka et al. (Can. J. Genet. Cytol. 28: 808—817, 1986)
discloses various characteristics of Wound repair in the
presence of tumorigenic and non-tumorigenic strains of A.

10

EHA105) is assayed by inoculating soybean (cv. Fayette)
cotyledonary node explants. On average, KYRT1 produced
many more transformed multicellular sectors than the com

15

parative strains, demonstrating that KYRT1 is equally or
more effective than the comparative strains (EHA105 and
GV3850) at delivering DNA into soybean in a binary vector

system.

tumefaciens and that soybean explants had recently been

BRIEF DESCRIPTION OF DRAWINGS

transformed.

From these prior disclosures, it is readily apparent that the
art Would signi?cantly advance With the addition of novel
strains of disarmed A. tumefaciens having a Wide host-range
and the ability to more ef?ciently transform plants, such as
soybean, that have here-to-date been refractory to

Agrobacterium-mediated transformation. Moreover, since
A. tumefaciens strains vary someWhat in their host range,
creating neW disarmed strains is expected to expand the list

FIGS. 1A—1C: Construction of PCH1B, triparental mat
20

(black bar) and the right border sequence (hatched bar)
25

of A. tumefaciens-transformable plant species.
It is thus one object of the invention to provide novel
disarmed A. tumefaciens strains that are ef?cient in the

30

transformation of economically important crops, in particu
lar soybean. Another object of the invention is to provide
novel methods for increasing the ef?ciency of A.

FIGS. 2A—2B: Southern Analysis of total DNA of Chry5,
35

Chry51B and KYRT, With probes of pTiChry5 T-DNA
region. Total DNA of Chry5, Chry51B and KYRT, and
cosmid DNA of pCH77 and PCH1B, Were digested With

dicots and monocots. Yet another object of the invention is
to provide novel methods for the transformation of plants,

particularly soybean. A further object of the invention is to
provide transgenic plants possessing one or more genetically
engineered desirable characteristics. These and other objects
of the invention, apparent from the disclosure herein, are
realiZed in the A. tumefaciens strains, exempli?ed by strain
KYRT1, under the practice of the invention.

(Kovacs and Peuppke, Mol. Gen. Genet. 242: 327—336,
1994). (B) depicts a map of pCH1B, containing the
[3-lactamase insert from pBSL167 (Alexeyev, M. F, et al.,
Gene 160(1): 63—67, 1995), With restriction sites for EcoRI
(E) and BamHI (B) marked. (C) presents a summary of the
tWo triparental mating steps to disarm Chry5, resulting in
homologous recombination betWeen pCH12 and pTiChry5.
The detailed insert of pTiChry5 shoWs the relative positions
of overlapping subclones pCH23 and pCH77, and the onco
genic T-DNA. BamHI sites and fragment numbers are also
indicated.

tumefaciens-mediated gene transfer, again particularly With
respect to soybean. In conjunction With the foregoing, it is
another object of the invention to provide novel genetically
engineered Ti plasmids useful in the transformation of both

ing. (A) depicts an EcoRI map of pTiChry5 subclone pCH77
shoWing the approximate locations of the oncogenic T-DNA

EcoRI and the fragments Were separated by agarose (0.8%

TAE) electrophoresis (10 ng/lane genomic DNA, approxi
40

mately 1 ng/lane pCH77 DNA and 0.1 ng/lane pCH1B
DNA). Southern hybridiZation Was conducted at 65° C.

using labelled probes of (A) subcloned pTiChry5 EcoRI
fragment 11 and (B) subcloned EcoRI fragment 9. Lanes are:
45

(1) cosmid clone pCH77, (2) intermediate construct pCH1B,
and total DNA of (3) Wild-type Chry5, (4) Chry51B, and (5)
KYRT. ArroW indicates the position of the chromosomal

SUMMARY OF THE INVENTION

fragment homologous to pTiChry5 EcoRI fragment 11.

The invention provides for disarmed strains of A. tame
DETAILED DESCRIPTION OF THE
INVENTION

faciens. The invention further provides for disarmed A.
tumefaciens derived from strain Chry5, Wherein the plasmid
pTiChry5 has a disarming mutation, such as deletion in part

Soybean is difficult to transform by engineered (i.e.,
disarmed) A. tumefaciens-mediated gene transfer.
Nevertheless, A. tumefaciens is the preferred system for

or all of the T-DNA. The invention also provides for a

disarmed A. tumefaciens designated KYRT1, and deriva
tives thereof, Which is particularly tumorigenic in dicots
including, for example, soybean, tomato and collard. The
invention additionally provides methods for the ef?cient
transformation of plants, and in particular soybean. The
invention also provides for transgenic plants transformed via

55

Therefore, a disarmed version of any strain that shoWs a

A. tumefaciens KYRT1 or derivatives thereof.

The invention is exempli?ed by A. tumefaciens strain

gene transfer since, With a susceptible host plant, it inte
grates foreign DNA into the host genome With high ef?
ciency and Without the degree of rearrangement or trunca
tion that typically occurs With direct DNA transfer methods,
such as particle bombardment and electroporation.

60

strong capacity for virulence on soybean represents a Wel

come breakthrough in the ?eld of soybean genetic engineer

KYRT1, Which is an avirulent version of A. tumefaciens

Chry5, a highly tumorigenic strain on soybean. Disarming is
accomplished by removing an approximately 18-kb BamHI

ing.

fragment of the 285-kb plasmid pTichry5, including

KYRT1 to ful?ll the need in the art and the objectives set
forth above. A. tumefaciens KYRT1 is a disarmed derivative

approximately 3 to 4-kb of the oncogenic T-DNA and the

right border. The deletion is accomplished by ?rst removing
the corresponding 18-kb region by BamHI digestion from a

The invention thus provides for A. tumefaciens strain
65

of the broad host range vector A. tumefaciens Chry5, Which

itself is highly tumorigenic on soybean.

5,929,306
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Medicago, Lycopersicon, Brassica, Cucumis, Solanum,
Juglans, Gossypium, Malus, Vitis, Antirrhinum, Populus,
Fragaria, Arabidopsis, Picea, Capsicum, Chenopodium,
Dendranthema, Pharbitis, Pinus, Pisum, OryZa, Glycine,

Disarming of A. tumefaciens strain Chry5 Was accom

plished by removing approximately 18-kb of the bacterium’s

tumor-inducing (Ti) plasmid (pTiChry5), Which included
6-kb of the oncogenic sequences comprising the transfer
DNA (T-DNA), Which during infection is mobiliZed into the
plant cell by the bacteria to generate the croWn gall symp

Pseudotsuga, Vinis, Kaleanchoe, Beta, Helianthus and Nic
otiana. Conifers are also preferred.
The invention as described herein is exempli?ed by the
deletion of T-DNA sequences betWeen tWo BamHI restric
tion sites in order to disarm the bacterium. HoWever, it Will

toms. The deleted sequences also include a short signal
sequence called a border, Which is essential for the mobili
Zation of the T-DNA. The deletion Was accomplished by ?rst

removing the corresponding 18-kb region by BamHI endo
nucleolytic digestion of plasmid pCH77, Which itself com
prises a 24-kb fragment of the Ti plasmid (pTiChry5) of A.
tumefaciens strain Chry5 cloned in the broad host-range
vector pLAFR1 (Friedman et al., Gene 18: 289—296, 1982)
(FIG. 1A). The deleted fragment Was replaced With a marker
gene, the [3-lactamase gene, Which confers resistance to the

be appreciated that other disarming mutations of Wide
host-range, highly tumorigenic Ti plasmids such as
pTiChry5 may be used in the practice of the invention.
Indeed, it is only necessary, in the case of a deletion, that
suf?cient T-DNA and/or border DNAbe removed to provide
15

the disabled phenotype. Moreover, disarming mutations
other than deletions may be used under the practice of the

invention, including (but not limited to), point mutations and

antibiotic carbenicillin (FIG. 1B). The resulting construct,
designated pCH1B, thus contained the [3-lactamase gene

insertions as Well as combinations of these mutational

?anked on each side by approximately 4-kb of Ti plasmid

methods.

sequence.

The invention is exempli?ed beloW using the cotyledon
and leaf regeneration system for the production of soybean
and tobacco, respectively. HoWever, other regeneration sys

Cosmid pCH1B Was then introduced into A. tumefaciens

strain Chry5 by bacterial conjugation generating Chry51B
(see beloW). Homologous recombination betWeen pCH1B

tems knoWn in the art may be used as Well. These include the

cotyledonary node, immature embryo and protoplast regen

and pTiChry5 Was forced by the introduction of plasmid

pPH1JI (Hirsch and Berenger, Plasmid 12: 139—141, 1984),
Which is incompatible With plasmid pLAFR1. The

eration systems as Well as others knoWn to those skilled in
25
the art.

recombinant, KYRT1, Was identi?ed by resistance to

The selection of transformed tissue is most usually

carbenicillin, rifampicin (the selection marker for A. tume
faciens strain Chry5), and gentamicin, a selection marker for
pPH1JI (FIG. 2). Bacteria surviving this selection are
expected to have the [3-lactamase gene integrated by
homologous recombination into pTiChry5 in place of the
deleted 18-kb T-DNA sequence, contain the free-living
pPH1JI, and to have lost pCH1B in the free-living cosmid
pLAFR1, Which rendered the strain tetracycline-sensitive.
Southern analysis Was performed con?rming the results of
the selection procedure, in Which the genomic and Ti plas
mid DNA of A. tumefaciens KYRT1 rendered the expected
results. The loss of the ability of the selected product to form

accomplished in plant regeneration by inserting an antibiotic
resistance gene into the transformed tissue. There is a large
number of such antibiotics useful for this purpose including,

for example, rifampicin, carbenicillin, chloramphenicol,

ampicillin, gentamicin, kanamycin, tetracycline, 2(N
Morpholine)ethanesulfonic acid (MES), hygromycin. Non
antibiotic selective agents, such as methotrexate, may also
35

be employed.
As pertaining to A. tumefaciens KYRT1 and its deriva
tives and obvious variants, the invention is not meant to be
limited to soybean transformation, as these vectors are
thought to be useful in the transformation of a Wide variety

Chry5 Wild-type progenitor (Table 1), further con?rmed that

of dicotyledonous and/or monocotyledonous plants.
Accordingly, While soybean is the preferred plant species,

the 18-kb of T-DNA had been deleted from A. tumefaciens

the practice of the methods of the invention and the claims

tumors on tomato and tobacco stems, compared With the

Chry5.

appended hereto are not meant to be limited in scope or spirit

to any particular plant species.

The use of strain KYRT1 With binary vectors having an

pPH1J I, Which Would be expelled by the introduction of, and

The utility of the present invention is Well apparent to
those skilled in the art, for it is Widely knoWn that soybean

selection for, that binary vector. This Was demonstrated by
introducing a binary vector (pBI121) containing an intron

is a major food and feed source and any improvements
therein under the practice of the invention Will serve to

containing [3-glucuronidase (GUS-INT) into A. tumefaciens

further increase the agronomic value of this plant. Moreover,

KYRT1. The binary vector conferred kanamycin-resistance

as discussed above, due to a limited genetic diversity, the
techniques and vectors of the invention alloW for the gen
eration of novel plant characteristics that have heretofore not

RK2 origin of replication is not hindered by the presence of

to the resulting strain. This strain Was also gentamicin
sensitive due to the loss of pPH1JI. Tobacco leaf pieces
inoculated With KYRTlzzGUS-INT produced GUS
transformed calli on culture medium containing hormones
and kanamycin. These calli formed shoots, Which Were

45

been possible to attain by traditional breeding methods.
The desirable characteristics that may be imparted on
55

groWn into normal rooted plants. Importantly, leaf pieces

plants, particularly soybean, under the practice of the inven

inoculated With KYRTlzzGUS-INT formed no callus When

tion include, but are not limited to, resistance to Water stress,
resistance to heat stress, resistance to cold stress, resistance

cultured on hormone-free medium, implying that the

to one or more insect pests, resistance to pesticides,

T-DNA, Which contains genes for phytohormone synthesis

increased yield and increased nutritional content.
It should also be appreciated that the A. tumefaciens and
methods of the present invention may be used to create
plants that act as a biofactory, producing any number of

in infected tissue, had been effectively rendered non
functional in KYRT1. Conversely, tissue inoculated With

Wild-type Chry5::GUS-INT generated callus on both
hormone-containing and hormone-free media, Which assay
ing positive for expression of the GUS-INT gene.
It Will be appreciated that While the preferred plant

species for transformation is soybean (Glycine max), other
species may also be used. These include those of the genus

65

desirable compounds. In this regard, production of pharma
ceutically active compositions, such as peptide hormones,
etc., and other useful protein(s) and polypeptides, including
mammalian and human proteins and polypeptides, may be
produced in large quantity and at reduced cost.

5,929,306
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What follows hereinafter are exemplary embodiments of
the invention, Wherein the preparation of a novel A.

medium containing the hormones cytokinin (BAP) and

tumefaciens, KYRT1, and its use in the generation of

INT formed calli at the inoculation sites, Whereas there Was
no callus formation in the absence of these hormones.

auxin (IAA), strain KYRT1::GUS-INT and EHA105::GUS

transgenic soybean is disclosed.

Moreover, calli and plantlets from calli inoculated With

METHODS

KYRT1::GUS-INT Were positive for GUS as indicated by
histochemical staining. These results indicate that A. tume
faciens KYRT1 has maintained a functional vir region, and

Construction of pCH1B
Cosmid clone pCH77 contains a 24 kb fragment of

pTiChry5 DNA including the oncogenic T-DNA and right
border in the pLAFR1 cosmid (Kovacs and Peuppke, Mol.
Gen. Genet. 242: 327—336, 1994). This clone Was digested
With BamHI and the vector sequences isolated by agarose

10

gel electrophoresis. Plasmid pBSL167 (Alexeyev, M. F., et
al., Gene 160(1): 63—67, 1995), Which contains the

Wild-type A. tumefaciens Chry5, KYRT1, A281 and

[3-lactamase gene and promoter ?anked by BamHI sites Was

similarly digested With BamHI and the insert corresponding

EHA105 (Which is a disarmed strain A281 as an avirulent
15

control). TWo day old cultures Were suspended to a density
of ca. 108 cells/ml in phosphate buffered saline (PBS) , and
applied With a 3 cm3 syringe through a 17-gauge needle. The
loWer leaves of the tobacco plant Were removed and the
exposed regions Were inoculated in tWo internodes, on

20

opposite sides of the stem. The stem Was scratched With a
needle, making a ca. 3 mm Wound, and the bacterial sus

to the [3-lactamase gene Was puri?ed by agarose electro

phoresis. The gel-isolated fragments Were ligated and used
to transform E. coli DHSO. and recombinants selected in the

presence of tetracycline (10 pig/ml) and ampicillin (100
pig/ml). The resulting construct, designated pCH1B, Was
veri?ed by restriction enZyme analysis.
Marker Exchange/Forced Recombination
Cosmid pCH1B Was transferred into A. tumefaciens

Chry5 using the triparental mating scheme With plasmid
pRK2013 as the helper plasmid (Ditta et al., Proc. Natl.
Acad. Sci. (USA), 77: 7347—7351, 1980). Transformed

25

bacterium Were selected in the presence of rifampicin (100

pig/ml) and carbenicillin (100 pig/ml). The resulting strain,
designated Chry51B, is also tetracycline resistant. This
strain presumably contains both pCH1B and intact

30

pTiChry5. The incompatible plasmid pPH1JI (Hirsch and
RK2 ori, Was next transferred into Chry51B and recombi

pBl121 (Clonetech, Inc.). Strains containing the binary

nants identi?ed by simultaneous selection on LB agar con
35

and gentamicin (40 pig/ml), the latter being the selection
marker for pPH1JI. This selection provided clones that had
undergone the intended double recombination event. The
sensitivity of certain of the resultant clones to tetracycline
(10 pig/ml) Was tested, to verify that the pLAFR1 cosmid

plasmid Were selected by resistance to kanamycin (100
pig/ml). The A. tumefaciens strains Were used to inoculate
excised leaves of aseptically groWn, one month old tobacco

(cv. Ky160) seedlings. TWo day bacterial cultures in 5 ml LB

medium containing rifampicin (100 pig/ml) and kanamycin
40

(100 pig/ml) Were tWice centrifuged and resuspended in 5 ml
LB Without antibiotics. Tobacco leaves are dipped into the
bacterial suspension and either halved or quartered. Leaf
sections are transferred to modi?ed Murashige and Skoog
medium containing 3% sucrose and the hormones indoleace

sequences had been lost in the recombination event. A clone

that is resistant to gentamicin, carbenicillin and rifampicin,
but sensitive to tetracycline Was selected and designated A.

tumefaciens KYRT1. The identity of the recombinant is
further veri?ed by Southern analysis of the Ti plasmid.

pension Was applied as a droplet to the freshly-made Wound.
Tomato plants are inoculated by piercing the stem With the
needle, at tWo internodes, and applying a droplet of bacterial
suspension at each of the Wound openings. Plants Were
maintained under greenhouse conditions and fertiliZed
Weekly With a N-P-K (20:20:20) fertiliZer. Tumor formation
Was scored by calculating the siZe of the tumor surface 5
Weeks after inoculation.
Tobacco Leaf Transformation

Abinary plasmid Was conjugated into Chry5, KYRT1 and
EHA105 by triparental mating as discussed above. The
Km-resistant plasmid contains the GUS-intron gene in

Berenger, Plasmid 12: 139—141, 1984), containing the IncP

taining rifampicin (100 pig/ml), carbenicillin (100 pig/ml)

can transfer foreign T-DNA containing heterologous genes,
from introduced binary vectors.
Stem Inoculation Assay
Stems from tWo-month old tobacco (cv. Ky14) and three
Week old tomato (cv. “Big Boy”) Were inoculated With

45

Stem and Leaf Inoculations
To test KYRT1 for loss of tumorigenicity, tobacco and
tomato plants Were inoculated With A. tumefaciens KYRT1

tic acid (1 mg/L) and benZyladenine (10 pM). After three
days incubation, the leaf sections are Washed in sterile Water,
blotted dry on sterile paper toWels and transferred either to

TOM medium (containing hormones) or T-medium (TOM

and Chry5 (see beloW). Disarmed A. tumefaciens strain
EHA105 (Hood et al., J. Bacteriol. 168(3): 1283—1290,

medium lacking hormones), containing mefoxin (500 mg/L)

1986) and its Wild-type progenitor A281, Were used as
controls. Five Weeks after the inoculation, large tumors of

to fresh medium after an additional three days and thereafter
every seven days.

comparable siZe had formed on 100% of the inoculation
sites for A. tumefaciens Chry5 and A281. In contrast, no
tumors formed on the inoculation sites for A. tumefaciens
KYRT1 and EHA105. One tobacco plant inoculated With
KYRT1 did, hoWever, shoW a small amount of blister, Which

Soybean Cotyledonary Node Explant Assays

and kanamycin (300 mg/L). Leaf explants Were transferred

Soybean seedling cotyledonary node explants Were inocu
55 lated With KYRT::GUS-INT as a test for stable transforma

tion of soybean. Disarmed A. tumefaciens strains GV3850
and EHA105, also containing GUS-INT Were also assayed
for comparative purposes. On average, explants inoculated

may have been due to environmental contamination or by a

non-agrobacterial callus formation. These results, then, indi
cate that the homologous recombination event in A. tume

With KYRT1::GUS-INT produced three times as many
60

GUS-positive sectors (as judged by histochemical staining)

faciens KYRT1 effectively removed the capacity for tumor

as explants inoculated With either GV3850::GUS-INT or

formation in that bacterium.
To further con?rm the loss of tumorigenicity in A. tume
faciens strain KYRT1, a GUS-INT construct Was used for
the transformation of tobacco leaves via Chry5, KYRT1 and

EHA105::GUS-INT. Based upon chi-square analysis, the

EH105. As expected, tumorigenic strain Chry5::GUS-INT
formed calli along the cut edges of inoculated leaves. In

65

difference betWeen KYRT1 and GV3850 Was signi?cant at
the 0.01 level, While that betWeen KYRT1 and EHA105 Was
signi?cant at the 0.05 level. These results demonstrate the

clear improvement in transformation ef?ciency using A.
tumefaciens strain KYRT1.
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Soybean Cotyledonary Nodes

disarmed vector for the transformation of soybean cotyle
donary node tissue.

Cotyledonary node cultures Were initiated from 3 day-old

The above-embodiments of the invention are meant to be
illustrative and are not to be construed as limiting on the

seedlings of soybean (cv. Fayette) (Townsend, J. A., Inter
national Patent Application No. WO 94/02620, 1994). A.
tumefaciens strains KYRT1, EHA105 and GV3850 contain

broad claims appended hereto. Obvious variants of the
embodiments disclosed are readily recogniZed by those

ing GUS-INT Were groWn as 1 ml cultures for tWo days in

skilled in the art and are meant to be Within the scope and

LB medium containing rifampicin (100 pig/ml) and kana
mycin (100 pig/ml). A. tumefaciens GV3850 and KYRT1
growth medium also contains carbenicillin (100 pig/ml).
These tWo-day cultures are used to inoculate 100 ml

spirit of the claims.
Each of the publications and patents cited herein are
10

cultures, Which are then groWn overnight to mid-log phase.

having ATCC Accession No. 202167.

aliquots in co-cultivation medium (Gamborg B5 medium

containing 44 pM benZyladenine, 0.5 pM indolebutyric acid
15

acetosytingone (100pM). Three day-old seedlings Were pre
pared (Veluthambi et al., J. Bacteriol. 170(4): 1523—1532,
1988; ToWnsend, International Patent Application No. WO
94/02620, 1994), and immersed in the bacterial suspension
for one hour. EXplants are cultured adaXial side up on

We claim:

1. A disarmed A grobacterium tumefaciens strain KYRT1,

Cultures Were pelleted and resuspended as tWo 10 ml

and buffered to pH 5.5 With 10 mM MES) containing

expressly incorporated herein by reference thereto.

2. A method of producing a transgenic plant comprising
the steps:
(a) introducing a binary vector comprising a gene of
interest into the disarmed Agrobacterium tumefaciens
strain of claim 1 to produce a recombinant A. tumefa

ciens;
(b) contacting said recombinantA. tumefaciens of With at
20

least one site on a plant tissue, Wherein said site

solidi?ed co-cultivation medium for three days, after Which
they are Washed With sterile Water, blotted dry and cultured
adaXial side doWn on counter-selection medium (Gamborg

comprises a Wound site, and said plant tissue is selected

B5 containing benZyladenine (5 pM), indolebutyric acid (0.5

(c) culturing said plant tissue to alloW regeneration of said

pM) and buffered to pH 5.7 With 3 mM MES), containing

from the group consisting of embryogenic, cotyledon
ous and somatic tissue; and
25

mefoXin (500 mg/L) and vancomycin (200 mg/L). After one

tissue into a transgenic plant.
3. The method of producing a transgenic plant according

Week, the eXplants are transferred to counter-selection

to claim 2, Wherein said plant tissue is a dicotyledonous

medium containing mefoXin (250 mg/L), vancomycin (100

plant tissue.
4. The method of producing a transgenic plant according

mg/L) and kanamycin (100 mg/L) and sub-cultured every
tWo to three Weeks thereafter. SiX Weeks after inoculation,
shoot masses that form at the base of the cotyledon are
harvested, cut into ca. 1.5 mm thick sections and assayed for

30

5. The method of producing a transgenic plant according
to claim 3, Wherein said dicotyledonous plant tissue is from

GUS activity by histochemical staining (Jefferson, Plant
Mol. Biol. Rep. 5: 387—405, 1987). On average, eXplants
inoculated With KYRTlzzGUS-INT produced three times as
many GUS-positive sectors as eXplants inoculated With
either GV3850zzGUS-INT or EHA105::GUS-INT. The dif
ference betWeen KYRT1 and GV3850 Was signi?cant to the
0.1 level based on chi-square analysis Whereas the difference
betWeen KYRT1 and EHA105 Was signi?cant at the 0.05

level, demonstrating that KYRT1 is indeed an improved

to claim 3, Wherein said dicoytyledonous plant tissue is

soybean (Glycine max) plant tissue.
a conifer or from a genus selected from the group consisting
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of Medicago, Lycopersicon, Brassica, Cucumis, Solanum,
Juglans, Gossypium, Malus, Vitis, Antirrhinum, Populus,

Fragaria, Arabidopsis, Picea, Capsicum, Chenopodium,
Dendranthema, Pharbitis, Pinus, Pisum, OryZa, Glycine,
Pseudotsuga, Kalanchoe, Beta, Helianthus and Nicotiana.
40
*

*

*

*

*

